9:22 AM
Leo Group India
| ||
| Drug makers join efforts in research Financial Express Pharmaceutical companies have collaborated before on areas considered not directly competitive, like finding variants in the human genome and biomarkers to predict disease and the effectiveness of drugs. But the people behind the new effort said it ... See all stories on this topic » | ||
| Swiss Drug Giant Picks Manhattan for Research Site New York Times Roche, the Swiss pharmaceutical giant, will open a new research center in Manhattan that will take on some of the former responsibilities of its big campus in Nutley, N.J.. Roche announced in June that it would shut the Nutley site, where the ... See all stories on this topic » | ||
| Surya Pharmaceutical Limited - Disclosure under SEBI Takeover Regulations Moneycontrol.com Surya Pharmaceutical Limited - Disclosure under SEBI Takeover Regulations. Emm Bee Fincap Private Limited has submitted to the Exchange vide letter dated September 18, 2012, a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial ... See all stories on this topic » | ||
| Unigene and Tarix Pharmaceuticals Report Highly Increased Oral Bioavailability ... Sacramento Bee BOONTON, N.J. and CAMBRIDGE, Mass., Sept. 19, 2012 -- /PRNewswire/ -- Unigene Laboratories, Inc. (OTCBB: UGNE) and Tarix Pharmaceuticals today announced the successful completion of a feasibility study of an oral formulation of TXA127, Tarix's lead ... See all stories on this topic » | ||
| Sickness sells: It helps pharmaceutical companies profit Moneylife The pharmaceutical companies laugh all their way to their banks! What is the result? Every symptom, however trivial it might be, gets blown out of proportion. Many of life's normal physiological processes like menarche, menopause, pregnancy, child ... See all stories on this topic » | ||
| Tonix Pharmaceuticals Highlights Therapeutic Programs on CEONEWS.Tv Equities.com NEW YORK, NY -- (Marketwire) -- 09/20/12 -- Tonix Pharmaceuticals Holding Corp. (OTCQB: TNXP) ("TONIX" or the "Company"), a specialty pharmaceutical company developing non-addictive treatments for chronic pain syndromes, including fibromyalgia ... See all stories on this topic » | ||
| Sunesis Pharmaceuticals Announces Closing of $40 Million in Previously ... Equities.com 20, 2012 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced the closing of two previously disclosed financings. Royalty Pharma has invested $25.0 million under its royalty arrangement with Sunesis, and, in a separate ... See all stories on this topic » | ||
| 25% of Pharmaceutical Companies Have No Dedicated Compliance Teams The Herald | HeraldOnline.com RESEARCH TRIANGLE PARK, N.C. — One-quarter of surveyed pharmaceutical companies do not have dedicated compliance teams in place, according to a new benchmarking study by Cutting Edge Information. Instead, these companies task ... See all stories on this topic » | ||
| Questcor sinks after Aetna cuts reimbursement coverage Economic Times America's third-largest health insurer, Aetna Inc, said it would no longer reimburse Questcor Pharmaceutical's sole drug for most diseases, wiping off more than $1 billion of the drugmaker's market value. In a clinical policy bulletin published on its ... See all stories on this topic » | ||
| Can Cyclacel Pharmaceuticals Keep Rising? (CYCC, KO, AAPL) SmallCap Network Every dollar of sales for Cyclacel Pharmaceuticals is valued at $66.66 in the share price. By contrast, the price-to-sales ratio for Apple (NASDAQ: AAPL) is 4.42. For Coca-Cola (NYSE: KO) the price-to-sales ratio is 3.65. Cyclacel Pharmaceuticals ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment